GenVec, Inc.

GenVec, Inc. is a clinical-stage biopharmaceutical company focused on developing cutting-edge therapeutics and vaccines using its adenovector gene delivery platform. The company has extensive experience in designing, testing, and manufacturing adenovectored product candidates for gene-based medicine. GenVec has successfully conducted clinical trials in the U.S., Europe, and Africa, and has collaborated with leading companies and organizations to address significant health concerns. The company's proprietary technology has been used to develop product candidates for hearing loss, foot and mouth disease in cattle, and other health conditions. GenVec is headquartered in Gaithersburg, Md. and is committed to advancing innovative therapies and vaccines.